![Journal of Personalized Medicine jpm-logo](https://pub.mdpi-res.com/img/journals/jpm-logo.png?0a63989a4c4c964c)
Journal Menu
► ▼ Journal Menu-
- JPM Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
15 July 2024
Journal of Personalized Medicine | Big Reviews Project 2024
We invite you to participate in the Big Reviews Project 2024 of the Journal of Personalized Medicine (JPM, ISSN: 2075-4426).
The Big Review Project aims to commission comprehensive review papers co-authored by at least 3 recognized experts with multiple affiliation units (at least 3 units) to increase our portfolio of influential reviews.
Requirements for Big Reviews:
- Author Requirements
- Leading authors should be senior Editorial Board Members and the first author to complete the Big Review. You may have a PostDoc or Ph.D. student in their final year assisting you (Ph.D. obtained or at least 3 publications);
- The authors should be from two continents, with at least three affiliations, and at least two authors should be as senior as the journal's Editorial Board Members.
- Scope of Big Reviews
Authors can submit their Big Review to the corresponding Section based on their research focus. For detailed information on each Section, please click https://www.mdpi.com/journal/jpm/sections. If you are interested, please contact the Editorial Office for consultation as soon as possible.
In addition, we have some recommended hot topics for your reference:
- Multi-omics analysis in cancer;
- Pharmacogenomics in human disease;
- Macrophage polarization in inflammatory diseases;
- Vaccinomics;
- Cancer, autophagy and apoptosis;
- Tumor microenvironment;
- Radiomics and radiogenomics;
- Artificial intelligence in diagnostics and/or therapeutics in personalized medicine;
- The tumor ecosystem: cellular interactions and therapeutic opportunities;
- Bioinformatics for clinical applications in precision medicine;
- Reconstructive microsurgery;
- Sex hormones and gender in disease mechanisms;
- lncRNAs in cancer;
- Outcomes after critical illness.
- Word Count
Big Reviews are expected to be a minimum of 6000 words.
- Benefits for authors
4.1 The lead (invited) author will receive a travel grant of CHF 500. The travel grant will be granted to the lead author when attending a conference and promoting MDPI and the published Big Review to your colleagues.
4.2 Other collaborators will receive a waiver for one submission to JPM. The other authors of Big Reviews, including non-leading authors, can enjoy one waiver for their other full research article or comprehensive review.
4.3 Authors will receive a PDF booklet containing a selection of comprehensive reviews, which are published in the Journal of Personalized Medicine.
4.4 All collaborators will be invited to join the journal’s physical meeting and online meeting. We will invite all Big Review authors to participate in journal-related theme meetings to provide you with a communication platform for interaction with outstanding Editorial Board Members.
Submission Guidelines:
- Manuscripts should be submitted online through the Journal of Personalized Medicine portal (https://www.mdpi.com/journal/jpm);
- Authors are encouraged to follow the journal's guidelines for formatting and referencing;
- All submissions will undergo a rigorous peer review process to ensure the highest quality and relevance to the Special Issue.
Submission Deadline: 31 December 2024.
For more details or inquiries, please contact the Editorial Office.
JPM Editorial Office